Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT)’s Relay Therapeutics RLAY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.17M	Buy	+619,652	New	+$5.54M	0.01%	1553
2025 Q1	–	Sell	-87,863	Closed	-$362K	–	3881
2024 Q4	$362K	Buy	+87,863	New	+$478K	﹤0.01%	2631
2024 Q3	–	Sell	-156,254	Closed	-$1.02M	–	3989
2024 Q2	$1.02M	Buy	156,254 +18,820	+14%	+$129K	﹤0.01%	1883
2024 Q1	$1.14M	Buy	137,434 +102,472	+293%	+$1,000K	﹤0.01%	2066
2023 Q4	$385K	Buy	+34,962	New	+$295K	﹤0.01%	2443
2023 Q3	–	Sell	-16,777	Closed	-$211K	–	4296
2023 Q2	$211K	Sell	16,777 -23,302	-58%	-$290K	﹤0.01%	1764
2023 Q1	$660K	Sell	40,079 -2,523	-6%	-$45.2K	﹤0.01%	1457
2022 Q4	$636K	Buy	+42,602	New	+$815K	﹤0.01%	1387
2022 Q3	–	Sell	-59,484	Closed	-$996K	–	2937
2022 Q2	$996K	Buy	+59,484	New	+$1.27M	0.01%	1105

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return